(Q57570988)

English

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

M V Glabbeke

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

I Judson

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

S Sleijfer

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

B Bui

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

P Schoffski

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

M Ouali

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

S Marreaud

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

V Brouste

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A Duhamel

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

P Hohenberger

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

S Mathoulin-Pelissier

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

0 references

publication date

19 April 2011

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

104

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1544-1550

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

https://scigraph.springernature.com/pub.10.1038/bjc.2011.136

0 references

How accurate are physicians in the prediction of patient survival in advanced lung cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Individual life expectancy estimation using validated prognostic scores for patients with cancer of unknown primary.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Development and validation of a bedside score to predict early death in cancer of unknown primary patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Early prediction of posttraumatic in-hospital mortality in pediatric patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Prospective validation of a prognostic score to improve patient selection for oncology phase I trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Predicting outcomes of neonates diagnosed with hypoxemic-ischemic encephalopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Progressive disease in patients with cancer presenting to an emergency room with acute symptoms predicts short-term mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Using single-agent therapy in adult patients with advanced soft tissue sarcoma can still be considered standard care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Soft-tissue sarcomas in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Interactions between psychosocial problems and management of asthma: who is at risk of dying?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Unmet needs in groups of traditionally underserved individuals with HIV/AIDS: empirical models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Statistical aspects of prognostic factor studies in oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Accuracy of predictions of survival in later stages of cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Prognostic uncertainty in terminal care: can the Karnofsky index help?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101912

2 November 2018

Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.136

21 January 2018

Clinical prediction of survival is more accurate than the Karnofsky performance status in estimating life span of terminally ill cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.136

21 January 2018

Prognostic factors among cancer patients with good performance status screened for phase I trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/21505457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The B12/CRP index as a simple prognostic indicator in patients with advanced cancer: a confirmatory study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21505457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Grade 3 nausea, vomiting, and myelosuppression or progressive, metastatic sarcoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21505457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/21505457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The last 3 months of life of cancer patients: medical aspects and role of home-care services in southern Switzerland

1 reference

https://pubmed.ncbi.nlm.nih.gov/21505457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting employment outcomes of rehabilitation clients with orthopedic disabilities: A CHAID analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21505457

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.2011.136

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21505457%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57570988&oldid=1409059164"